Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ

Andrzej Slominski, Ralf Paus, Przemyslaw Plonka, Bori Handjiski, Marcus Maurer, Ashok Chakraborty, Martin C. Mihm

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Here we show that cyclophosphamide induces disruption of follicular melanogenesis, which is characterized by abnormal transfer of pigment granules to ectopic hair bulb locations, extrafollicular melanin incontinence, disordered formation of melanosomes, and inhibition of melanosome transfer into precortical keratinocytes. This is in contrast to dexamethasone-induced termination of follicle melanogenesis, which activates premature but predominantly normal catagen development. Cyclophosphamide-induced pigmentation disruption was accompanied by significant alterations of biochemical and biophysical markers of melanogenesis, compared to control mice treated either with vehicle or with topical dexamethasone. Electron paramagnetic resonance spectroscopy shows a decline in the melanin signal and predominant eumelanin production. Tyrosine hydroxylase activity of tyrosinase and dihydroxyphenylalanine oxidation drop rapidly, while DOPAchrome tautomerase activity increases and dihydroxyindole carboxylic acid conversion factor activity remains unchanged in cyclophosphamide-treated mice compared to controls. These observations emphasize the key role of tyrosinase as opposed to post-dihydroxyphenylalanine oxidase steps in normal and pathological termination of melanogenesis and shows that tyrosinase is the most sensitive target of the melanogenic apparatus for pharmacological regulation. Follicle pigmentation recovers only during the subsequent hair cycle, i.e., after a new anagen hair bulb has been constructed, which points to the existence of a relatively chemoresistant melanoblast-like cell population residing in the noncycling part of the hair follicle.

Original languageEnglish (US)
Pages (from-to)1203-1211
Number of pages9
JournalJournal of Investigative Dermatology
Volume106
Issue number6
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Monophenol Monooxygenase
Hair Follicle
Melanocytes
Pigmentation
Hair
Cyclophosphamide
Melanosomes
Dihydroxyphenylalanine
Melanins
Pharmacology
Recovery
Dexamethasone
Pharmaceutical Preparations
Electron Spin Resonance Spectroscopy
Tyrosine 3-Monooxygenase
Carboxylic Acids
Keratinocytes
Pigments
Paramagnetic resonance
Spectrum Analysis

Keywords

  • alopecia
  • C57BL/6
  • chemoth erapy
  • DOPAchrome
  • EPR
  • melanin
  • tautomerase
  • tyrosinase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. / Slominski, Andrzej; Paus, Ralf; Plonka, Przemyslaw; Handjiski, Bori; Maurer, Marcus; Chakraborty, Ashok; Mihm, Martin C.

In: Journal of Investigative Dermatology, Vol. 106, No. 6, 01.01.1996, p. 1203-1211.

Research output: Contribution to journalArticle

Slominski, Andrzej ; Paus, Ralf ; Plonka, Przemyslaw ; Handjiski, Bori ; Maurer, Marcus ; Chakraborty, Ashok ; Mihm, Martin C. / Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. In: Journal of Investigative Dermatology. 1996 ; Vol. 106, No. 6. pp. 1203-1211.
@article{a8aff15ce8ca4f0696dbdd6180b3cfbb,
title = "Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ",
abstract = "Here we show that cyclophosphamide induces disruption of follicular melanogenesis, which is characterized by abnormal transfer of pigment granules to ectopic hair bulb locations, extrafollicular melanin incontinence, disordered formation of melanosomes, and inhibition of melanosome transfer into precortical keratinocytes. This is in contrast to dexamethasone-induced termination of follicle melanogenesis, which activates premature but predominantly normal catagen development. Cyclophosphamide-induced pigmentation disruption was accompanied by significant alterations of biochemical and biophysical markers of melanogenesis, compared to control mice treated either with vehicle or with topical dexamethasone. Electron paramagnetic resonance spectroscopy shows a decline in the melanin signal and predominant eumelanin production. Tyrosine hydroxylase activity of tyrosinase and dihydroxyphenylalanine oxidation drop rapidly, while DOPAchrome tautomerase activity increases and dihydroxyindole carboxylic acid conversion factor activity remains unchanged in cyclophosphamide-treated mice compared to controls. These observations emphasize the key role of tyrosinase as opposed to post-dihydroxyphenylalanine oxidase steps in normal and pathological termination of melanogenesis and shows that tyrosinase is the most sensitive target of the melanogenic apparatus for pharmacological regulation. Follicle pigmentation recovers only during the subsequent hair cycle, i.e., after a new anagen hair bulb has been constructed, which points to the existence of a relatively chemoresistant melanoblast-like cell population residing in the noncycling part of the hair follicle.",
keywords = "alopecia, C57BL/6, chemoth erapy, DOPAchrome, EPR, melanin, tautomerase, tyrosinase",
author = "Andrzej Slominski and Ralf Paus and Przemyslaw Plonka and Bori Handjiski and Marcus Maurer and Ashok Chakraborty and Mihm, {Martin C.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1111/1523-1747.ep12348479",
language = "English (US)",
volume = "106",
pages = "1203--1211",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ

AU - Slominski, Andrzej

AU - Paus, Ralf

AU - Plonka, Przemyslaw

AU - Handjiski, Bori

AU - Maurer, Marcus

AU - Chakraborty, Ashok

AU - Mihm, Martin C.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Here we show that cyclophosphamide induces disruption of follicular melanogenesis, which is characterized by abnormal transfer of pigment granules to ectopic hair bulb locations, extrafollicular melanin incontinence, disordered formation of melanosomes, and inhibition of melanosome transfer into precortical keratinocytes. This is in contrast to dexamethasone-induced termination of follicle melanogenesis, which activates premature but predominantly normal catagen development. Cyclophosphamide-induced pigmentation disruption was accompanied by significant alterations of biochemical and biophysical markers of melanogenesis, compared to control mice treated either with vehicle or with topical dexamethasone. Electron paramagnetic resonance spectroscopy shows a decline in the melanin signal and predominant eumelanin production. Tyrosine hydroxylase activity of tyrosinase and dihydroxyphenylalanine oxidation drop rapidly, while DOPAchrome tautomerase activity increases and dihydroxyindole carboxylic acid conversion factor activity remains unchanged in cyclophosphamide-treated mice compared to controls. These observations emphasize the key role of tyrosinase as opposed to post-dihydroxyphenylalanine oxidase steps in normal and pathological termination of melanogenesis and shows that tyrosinase is the most sensitive target of the melanogenic apparatus for pharmacological regulation. Follicle pigmentation recovers only during the subsequent hair cycle, i.e., after a new anagen hair bulb has been constructed, which points to the existence of a relatively chemoresistant melanoblast-like cell population residing in the noncycling part of the hair follicle.

AB - Here we show that cyclophosphamide induces disruption of follicular melanogenesis, which is characterized by abnormal transfer of pigment granules to ectopic hair bulb locations, extrafollicular melanin incontinence, disordered formation of melanosomes, and inhibition of melanosome transfer into precortical keratinocytes. This is in contrast to dexamethasone-induced termination of follicle melanogenesis, which activates premature but predominantly normal catagen development. Cyclophosphamide-induced pigmentation disruption was accompanied by significant alterations of biochemical and biophysical markers of melanogenesis, compared to control mice treated either with vehicle or with topical dexamethasone. Electron paramagnetic resonance spectroscopy shows a decline in the melanin signal and predominant eumelanin production. Tyrosine hydroxylase activity of tyrosinase and dihydroxyphenylalanine oxidation drop rapidly, while DOPAchrome tautomerase activity increases and dihydroxyindole carboxylic acid conversion factor activity remains unchanged in cyclophosphamide-treated mice compared to controls. These observations emphasize the key role of tyrosinase as opposed to post-dihydroxyphenylalanine oxidase steps in normal and pathological termination of melanogenesis and shows that tyrosinase is the most sensitive target of the melanogenic apparatus for pharmacological regulation. Follicle pigmentation recovers only during the subsequent hair cycle, i.e., after a new anagen hair bulb has been constructed, which points to the existence of a relatively chemoresistant melanoblast-like cell population residing in the noncycling part of the hair follicle.

KW - alopecia

KW - C57BL/6

KW - chemoth erapy

KW - DOPAchrome

KW - EPR

KW - melanin

KW - tautomerase

KW - tyrosinase

UR - http://www.scopus.com/inward/record.url?scp=0029930653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029930653&partnerID=8YFLogxK

U2 - 10.1111/1523-1747.ep12348479

DO - 10.1111/1523-1747.ep12348479

M3 - Article

VL - 106

SP - 1203

EP - 1211

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 6

ER -